HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunotoxicity of 3 chemical forms of beryllium following inhalation exposure.

Abstract
The toxicity of 3 chemical forms of beryllium (Be) was compared in this study. A total of 160 mice equally divided into 4 groups were exposed by inhalation (nose only) for 3 consecutive weeks, 5 d/week, 6 h/d. One group was used as control, while the 3 others were exposed to fine particles of Be metal, Be oxide (BeO), or Be aluminum (BeAl). Except for the controls, the target level of exposure was 250 μg/m(3). In all, 35 mice/group were sacrificed 1 week postexposure and another 5 mice 3 weeks postexposure. The BeO group showed the highest lung Be concentration with higher interleukin 12 (IL-12) and interferon-γ (IFN-γ) levels, while the Be group produced the most severe lung inflammation and higher tumor necrosis factor-α (TNF-α) and CD4+ T cells levels. Data suggested that Be and BeO apparently produced more pulmonary toxicity than BeAl. However, this conclusion is not definitive, because of different confounding factors such as particle sizes, specific surface area, and solubility.
AuthorsCaroline Muller, Fariba Salehi, Bruce Mazer, Michèle Bouchard, Ariane Adam-Poupart, Gaston Chevalier, Ginette Truchon, Jean Lambert, Joseph Zayed
JournalInternational journal of toxicology (Int J Toxicol) Vol. 30 Issue 5 Pg. 538-45 (Oct 2011) ISSN: 1092-874X [Electronic] United States
PMID22013136 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Tumor Necrosis Factor-alpha
  • Interleukin-12
  • beryllium oxide
  • Interferon-gamma
  • Beryllium
Topics
  • Animals
  • Beryllium (chemistry, toxicity)
  • CD4-Positive T-Lymphocytes (drug effects)
  • Dose-Response Relationship, Drug
  • Inhalation Exposure
  • Interferon-gamma (analysis)
  • Interleukin-12 (analysis)
  • Lung (drug effects, pathology)
  • Male
  • Mice
  • Mice, Inbred C3H
  • Particle Size
  • Tumor Necrosis Factor-alpha (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: